Topic Menu
► Topic MenuTopic Editors
New Strategies for Microbiological Control in Reproduction
Topic Information
Dear Colleagues，
The use of different strategies to avoid microbial contamination is essential in the different reproductive techniques. In artificial insemination of domestic animals, antibiotics are added to semen extenders, and prophylaxis is a common strategy in hormonally synchronized females to prevent infections that would compromise the success of the whole procedure.
Regarding human reproduction, antibiotic prophylaxis is also used to prevent potential infections derived from different assisted reproductive technologies, including hysteroscopy, laparoscopy, oocyte retrieval and embryo transfer. However, the use of antibiotic prophylaxis is not recommended as a general procedure, both because of secondary effects and as a strategy to slow down the appearance of antibiotic resistance. In fact, different infections of the reproductive tract that have been traditionally treated with antibiotics are becoming resistant to these agents and the need for new candidate strategies to treat them has become an urgent task.
Different organizations worldwide have recommended the limitation of the use of antibiotics to avoid the appearance of new antibiotic-resistance organisms, which is a priority issue to be addressed from all areas of health, including human and animal health to support One Health approach. Considering that, the limitation and promotion of alternatives to antibiotic use in reproduction is one of the main objectives that must be achieved in the short time.
This Topic is focused into finding new strategies for microbial control in reproduction, including animal and human species.
Dr. Ariadna Delgado
Dr. Jordi Ribas-Maynou
Dr. Carolina Maside
Dr. Lorena Padilla
Topic Editors
Keywords
- reproduction
- antibiotic
- antibiotic resistance
- assisted reproductive techniques
- microbial contamination
Participating Journals
| Journal Name | Impact Factor | CiteScore | Launched Year | First Decision (median) | APC |
|---|---|---|---|---|---|
Antibiotics
|
4.3 | 7.3 | 2012 | 15.8 Days | CHF 2900 |
Biomedicines
|
3.9 | 5.2 | 2013 | 14.6 Days | CHF 2600 |
Clinics and Practice
|
1.7 | 2.6 | 2011 | 20.8 Days | CHF 1600 |
Journal of Clinical Medicine
|
3.0 | 5.7 | 2012 | 16 Days | CHF 2600 |
Reproductive Medicine
|
1.1 | - | 2020 | 30.8 Days | CHF 1000 |
Preprints.org is a multidisciplinary platform offering a preprint service designed to facilitate the early sharing of your research. It supports and empowers your research journey from the very beginning.
MDPI Topics is collaborating with Preprints.org and has established a direct connection between MDPI journals and the platform. Authors are encouraged to take advantage of this opportunity by posting their preprints at Preprints.org prior to publication:
- Share your research immediately: disseminate your ideas prior to publication and establish priority for your work.
- Safeguard your intellectual contribution: Protect your ideas with a time-stamped preprint that serves as proof of your research timeline.
- Boost visibility and impact: Increase the reach and influence of your research by making it accessible to a global audience.
- Gain early feedback: Receive valuable input and insights from peers before submitting to a journal.
- Ensure broad indexing: Web of Science (Preprint Citation Index), Google Scholar, Crossref, SHARE, PrePubMed, Scilit and Europe PMC.
